CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −2,379 | $330.53 | $786K | 18,621 |
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −6,523 | $331.79 | $2.2M | 12,098 |
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −8,177 | $332.71 | $2.7M | 3,921 |
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −2,823 | $333.64 | $942K | 1,098 |
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −1,000 | $334.85 | $335K | 98 |
| 2021-07-15 | Huang Jane CMO, Hematology | Sale | −98 | $335.76 | $33K | 0 |
| 2021-07-15 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −89,882 | 122,798 | ||
| 2021-07-15 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −114,803 | 347,776 | ||
| 2021-07-15 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −68,315 | 204,971 | ||
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −51,300 | $24.24 | $1.2M | 6,085,580 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −400 | $310.64 | $124K | 15,481 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −600 | $312.31 | $187K | 14,881 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,600 | $313.23 | $501K | 13,281 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,309 | $314.53 | $412K | 11,972 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −700 | $315.64 | $221K | 11,272 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −945 | $316.79 | $299K | 10,327 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −300 | $318.03 | $95K | 10,027 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,100 | $319.43 | $351K | 8,927 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −4,524 | $320.20 | $1.4M | 4,403 |
| 2021-07-08 | OYLER JOHN Chief Executive Officer | Sale | −2,500 | $321.15 | $803K | 1,903 |
Page 65 of 99 · 1,972 trades